Abstract:Alteration of the lung microbiome has been observed in several respiratory tract diseases. However, most previous studies were based on 16S ribosomal RNA and shotgun metagenome sequencing; the viability and functional activity of the microbiome, as well as its interaction with host immune systems, have not been well studied. To characterize the active lung microbiome and its associations with host immune response and clinical features, we applied metatranscriptome sequencing to bronchoalveolar lavage fluid (BALF) samples from 25 patients with chronic obstructive pulmonary disease (COPD) and from nine control cases without known pulmonary disease. Community structure analyses revealed three distinct microbial compositions, which were significantly correlated with bacterial biomass, human Th17 immune response, and COPD exacerbation frequency. Specifically, samples with transcriptionally active Streptococcus, Rothia, or Pseudomonas had bacterial loads 16 times higher than samples enriched for Escherichia and Ralstonia. These high-bacterial-load samples also tended to undergo a stronger Th17 immune response. Furthermore, an increased proportion of lymphocytes was found in samples with active Pseudomonas. In addition, COPD patients with active Streptococcus or Rothia infections tended to have lower rates of exacerbations than patients with active Pseudomonas and patients with lower bacterial biomass. Our results support the idea of a stratified structure of the active lung microbiome and a significant host-microbe interaction. We speculate that diverse lung microbiomes exist in the population and that their presence and activities could either influence or reflect different aspects of lung health.IMPORTANCE Recent studies of the microbiome proposed that resident microbes play a beneficial role in maintaining human health. Although lower respiratory tract disease is a leading cause of sickness and mortality, how the lung microbiome interacts with human health remains largely unknown. Here we assessed the association between the lung microbiome and host gene expression, cytokine concentration, and over 20 clinical features. Intriguingly, we found a stratified structure of the active lung microbiome which was significantly associated with bacterial biomass, lymphocyte proportion, human Th17 immune response, and COPD exacerbation frequency. These observations suggest that the microbiome plays a significant role in lung homeostasis. Not only microbial composition but also active functional elements and host immunity characteristics differed among different individuals. Such diversity may partially account for the variation in susceptibility to particular diseases.

The Lower Airway Microbiome in Paediatric Health and Chronic Disease

Transcriptionally Active Lung Microbiome And Its Association With Bacterial Biomass And Host Inflammatory Status

The Human Respiratory Microbiome: Current Understandings and Future Directions

The Respiratory Microbiome in Paediatric Chronic Wet Cough: What Is Known and Future Directions

The Lung Microbiome

A clinicians' review of the respiratory microbiome

Bacterial Signatures of Paediatric Respiratory Disease: An Individual Participant Data Meta-Analysis

The microbiome: an integral player in immune homeostasis and inflammation in the respiratory tract

Microbiome effects on immunity, health and disease in the lung

Genomic attributes of airway commensal bacteria and mucosa

The Longitudinal Microbial and Metabolic Landscape of infant Cystic Fibrosis: The gut-lung axis

Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases

The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease

Lung Microbiome in Children with Hematological Malignancies and Lower Respiratory Tract Infections.

The airway microbiota of neonates colonized with asthma-associated pathogenic bacteria

Lung Microbiota and Its Impact on the Mucosal Immune Phenotype

The dynamic lung microbiome in health and disease

Human matters in asthma: Considering the microbiome in pulmonary health

Understanding the clinical implications of the "non-classical" microbiome in chronic lung disease: a viewpoint

Lung cancer: a new frontier for microbiome research and clinical translation

Microbiological characteristics of the lower airway in adults with bronchiectasis: a prospective cohort study